Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Hsu PI, Tsay FW, Kao JY, Peng NJ, Tsai KW, Tsai TJ, Kuo CH, Kao SS, Wang HM, Chen YH, Shie CB, Wu DC; Taiwan Acid-related Disease & Microbiota (TARD-M) Consortium.
Hsu PI, et al. Among authors: chen yh.
J Gastroenterol Hepatol. 2020 Oct;35(10):1731-1737. doi: 10.1111/jgh.15034. Epub 2020 Mar 31.
J Gastroenterol Hepatol. 2020.
PMID: 32167605
Free article.
Clinical Trial.